Floatz logo

Talaporfin

Liver And Intrahepatic Bile Duct Neoplasm

Light Sciences OncologySmall moleculePhase 3Dormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
62/ 100
Competitive Position
81/ 100

Competitive context

21 Active assets in the Liver And Intrahepatic Bile Duct Neoplasm cohort.

Asset / SponsorPhaseRating
Irinotecan
Tehran University of Medical Sciences
Phase 4BBB
Albumin Aggregated
Sirtex Medical
Phase 4BB
Chlorhexidine
Changhua Christian Hospital
Phase 4BB
Xaliplatin
Shanghai Zhongshan Hospital
Phase 4BB
Fluorouracilum
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 4BB

View all 49 →

Same molecule, other indications

Talaporfin is also rated in:

hepatocellular carcinomaDormant
BB
Indicative · Phase 3
64 / 100
View asset →
metastatic neoplasmDormant
B
Indicative · Phase 3
62 / 100
View asset →
colorectal neoplasmDormant
B
Indicative · Phase 3
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →